Russia vs Upper middle income: Prevalence of hypertension, male
Russia
47.3%
in 2019
Upper middle income
33.6%
in 2019
Russia rank
26th
Upper middle income rank
26th
Prevalence of hypertension, male over time
- Russia
- Upper middle income
How they compare
Russia currently reports 47.3% against 33.6% in Upper middle income, a difference of 13.7%.
That makes Russia's figure about 1.4 times Upper middle income's.
Across all 30 years both countries report, Russia has been ahead every year.
Russia ranks 26th and Upper middle income ranks 26th of 192 countries.
Russia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Russia | Upper middle income | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 51.5% | 29.3% | 22.2% | Russia |
| 2000s | 52.3% | 33.1% | 19.2% | Russia |
| 2010s | 49.5% | 33.9% | 15.6% | Russia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hypertension, male, Russia or Upper middle income?
- Russia, at 47.3% against 33.6% in Upper middle income as of 2019.
- What is the difference in prevalence of hypertension, male between Russia and Upper middle income?
- 13.7%, with Russia ahead.
- How many years of comparable data are there for Russia and Upper middle income?
- 30 years are reported by both, from 1990 to 2019.
- How do Russia and Upper middle income rank globally for prevalence of hypertension, male?
- Russia ranks 26th and Upper middle income ranks 26th of 192 countries.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Prevalence of hypertension, male (% of male adults ages 30-79). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of hypertension, male, is the percentage of male adults ages 30-79 with hypertension (defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension). The data is age-standardized.